Companies Dominating the Inhaled Nitric Oxide Delivery Systems Landscape
- Mallinckrodt Pharmaceuticals
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Getinge
- Vero Biotech
- LINDE
- Beyond Air
- SLE
- NU MED
- Bellerophon Therapeutics
- Circassia Pharmaceuticals
- Air Liquide Healthcare
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Inhaled Nitric Oxide Delivery Systems Market in 2025 is assessed at USD 382.26 million.
The global market size was worth more than USD 368.41 million in 2024 and is poised to witness a CAGR of over 4.7%, crossing USD 669.33 million revenue by 2037.
North America is projected to reach USD 234.27 million by 2037, fueled by COPD prevalence and growing INO therapy adoption.
The major players in the market include Beyond Air, SLE, NU MED, Bellerophon Therapeutics, Mallinckrodt Pharmaceuticals, Air Liquide Healthcare, and others.
